- Home
- FVCB vs ADCT Comparison
FVCB vs ADCT Comparison
Compare FVCB & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FVCB
- ADCT
- Stock Information
- Founded
- FVCB 2007
- ADCT 2011
- Country
- FVCB United States
- ADCT Switzerland
- Employees
- FVCB N/A
- ADCT N/A
- Industry
- FVCB Major Banks
- ADCT Biotechnology: Pharmaceutical Preparations
- Sector
- FVCB Finance
- ADCT Health Care
- Exchange
- FVCB Nasdaq
- ADCT Nasdaq
- Market Cap
- FVCB 248.5M
- ADCT 224.3M
- IPO Year
- FVCB N/A
- ADCT 2020
- Fundamental
- Price
- FVCB $11.81
- ADCT $1.83
- Analyst Decision
- FVCB
- ADCT Strong Buy
- Analyst Count
- FVCB 0
- ADCT 5
- Target Price
- FVCB N/A
- ADCT $8.00
- AVG Volume (30 Days)
- FVCB 24.5K
- ADCT 741.7K
- Earning Date
- FVCB 01-28-2025
- ADCT 03-12-2025
- Dividend Yield
- FVCB N/A
- ADCT N/A
- EPS Growth
- FVCB N/A
- ADCT N/A
- EPS
- FVCB 0.27
- ADCT N/A
- Revenue
- FVCB $45,550,000.00
- ADCT $70,717,000.00
- Revenue This Year
- FVCB N/A
- ADCT $6.58
- Revenue Next Year
- FVCB $14.51
- ADCT $11.78
- P/E Ratio
- FVCB $43.28
- ADCT N/A
- Revenue Growth
- FVCB N/A
- ADCT N/A
- 52 Week Low
- FVCB $9.78
- ADCT $1.68
- 52 Week High
- FVCB $14.50
- ADCT $6.04
- Technical
- Relative Strength Index (RSI)
- FVCB 43.16
- ADCT 43.64
- Support Level
- FVCB $11.27
- ADCT $1.68
- Resistance Level
- FVCB $12.40
- ADCT $2.14
- Average True Range (ATR)
- FVCB 0.62
- ADCT 0.14
- MACD
- FVCB -0.01
- ADCT -0.00
- Stochastic Oscillator
- FVCB 24.38
- ADCT 29.81
About FVCB FVCBankcorp Inc.
FVCBankcorp Inc is a registered bank holding company. It operates through the sole subsidiary, FVCbank which is a community-oriented, locally-owned, and managed commercial bank. It offers commercial banking services to small and medium-sized businesses, professionals, non-profit organizations and associations, and investors. It also provides retail banking services to accommodate the individual needs of both corporate customers as well as the communities it serves. The bank provides other facilities such as online banking, mobile banking, remote deposit service, and lending products, among others. Its primary source of revenue is the net interest income.
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.